Fate Therapeutics OverviewFate Therapeutics Other Income Expense Net
Other Income/Expense Net for FATE.
Quarterly Other Income/Expense
$1.79M
↓ 51.16% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$9.52M
↓ 61.33% YoY
Trailing 12 months ending Mar 31, 2026